The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Open accessAbstract
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years.Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex.Findings During 50 years of observation (202,417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20·4 to 96·2 cases per 1000 person-years in men and from 13·7 to 49·4 cases per 1000 person-years in women; age-adjusted incidence increased from 3·7 to 13·4 new cases per 1000 person-years in men and from 2·5 to 8·6 new cases per 1000 person-years in women (ptrend<0·0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12·6 in 1958-67 to 25·7 in 1998-2007 in men, ptrend=0·0007; 8·1 to 11·8 in women, ptrend=0·009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3·77, 95% CI 1·98-7·20 in 1958-1967 compared with 1998-2007; ptrend=0·0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1·34, 95% CI 0·97-1·86 in 1958-1967 compared with 1998-2007; ptrend=0·003) in 20 years following atrial fibrillation onset.Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.Funding NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly to incidence, age-adjusted prevalence of AF has been reported to be lower in women than in men in North America and Europe (Figure 2) (Supplementary Tables S3 and S4).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertension (treated) vs. none 19 HR 1.32 (95% CI 1.08-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Heart failure vs. none 19 HR 1.43 (95% CI 0.85-2.40)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Older age 19 50-59 years 60-69 years 70-79 years 80-89 years HR: 1.00 (reference) 4.98 (95% CI 3.49-7.10) 7.35 (95% CI 5.28-10.2) 9.33 (95% CI 6.68-13.0)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Obesity 19, 208 none (BMI < 25 kg/m²) overweight (BMI 25-30 kg/m²) obese (BMI ≥ 31 kg/m²) HR: 1.00 (reference) 1.13 (95% CI 0.87-1.46)1.37 (95% CI 1.05-1.78)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Myocardial infarction vs. none 19 HR 1.46 (95% CI 1.07-1.98)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Diabetes mellitus vs. none 19 HR 1.25 (95% CI 0.98-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“In North American and European populations, the age-adjusted incidence of AF has been estimated to be 1.5 to 2 times higher in men than in women (Supplementary Tables S1 and S2).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Elevated body mass index, hypertension, diabetes mellitus, coronary heart disease, valvular heart disease, and heart failure (HF) constitute major risk factors for AF, but the prevalence of these risk factors vary between women and men.3–5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Women with AF have higher prevalence of hypertension and valvular heart disease and lower prevalence of coronary heart disease than men with AF.5,11,34”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“However, in studies from North America,5 Europe,34,35 and Australia,11 women with AF are, on average, older than men.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“In particular, body mass index has increased significantly (Figure 3).5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,594
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Attia, Z. I., Noseworthy, P. A., Lopez-Jimenez, F., Asirvatham, S. J., Deshmukh, A. J., Gersh, B. J., Carter, R. E., Yao, X., Rabinstein, A. A., Erickson, B. J., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31721-0 · Cited by 1,613
Epidemiology of Atrial Fibrillation in the 21st Century
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020) · Circulation Research · doi:10.1161/circresaha.120.316340 · Cited by 1,625
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Stærk, L., Sherer, J. A., Ko, D., Benjamin, E. J., & Helm, R. H. (2017) · Circulation Research · doi:10.1161/circresaha.117.309732 · Cited by 1,267
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Self-citationAtrial Fibrillation Begets Heart Failure and Vice Versa
Santhanakrishnan, R., Wang, N., Larson, M. G., Magnani, J. W., McManus, D. D., Lubitz, S. A., Ellinor, P. T., Cheng, S. C., Vasan, R. S., Lee, D. S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018614 · Cited by 874
Brundel, B. J. J. M., Ai, X., Hills, M. T., Kuipers, M. F., Lip, G. Y. H., & de Groot, N. M. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00347-9 · Cited by 545
Magnussen, C., Niiranen, T., Ojeda, F., Gianfagna, F., Blankenberg, S., Njølstad, I., Vartiainen, E. A., Sans, S., Pasterkamp, G., Hughes, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028981 · Cited by 487
Tsao, C. W., & Vasan, R. S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv337 · Cited by 457
Self-citationAtrial fibrillation: epidemiology, screening and digital health
Linz, D., Gawalko, M. M., Betz, K., Hendriks, J., Lip, G. Y. H., Vinter, N., Guo, Y., & Johnsen, S. P. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100786 · Cited by 476
Stærk, L., Wang, B., Preis, S. R., Larson, M. G., Lubitz, S. A., Ellinor, P. T., McManus, D. D., Ko, D., Weng, L.-C. C., Lunetta, K. L., et al. (2018) · BMJ · doi:10.1136/bmj.k1453 · Cited by 392
Epidemiology and modifiable risk factors for atrial fibrillation
Elliott, A. D., Middeldorp, M. E., Gelder, I. C. V., Albert, C. M., & Sanders, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00820-8 · Cited by 392
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353
Wong, C. X. J., Ganesan, A. N., & Selvanayagam, J. B. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw045 · Cited by 357
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
Defining Dysbiosis for a Cluster of Chronic Diseases
Wilkins, L. J., Monga, M., & Miller, A. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-49452-y · Cited by 339
Sex differences in stroke: Challenges and opportunities
Bushnell, C., Chaturvedi, S., Gage, K. R., Herson, P. S., Hurn, P. D., Jiménez, M. C., Kittner, S. J., Madsen, T. E., McCullough, L. D., McDermott, M., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18793324 · Cited by 309
Cardiovascular Research Using the Korean National Health Information Database
Choi, E. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2020.0171 · Cited by 304
Linde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 308
Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults
Khurshid, S. S., Choi, S. H., Weng, L.-C. C., Wang, E. Y., Trinquart, L., Benjamin, E. J., Ellinor, P. T., & Lubitz, S. A. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006273 · Cited by 290
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
Bassand, J., Accetta, G., Camm, A. J., Cools, F. J. S., Fitzmaurice, D. A., Fox, K. A. A., Goldhaber, S. Z., Goto, S., Haas, S. K., Hacke, W., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw233 · Cited by 288
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
Lane, D. A., Skjøth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005155 · Cited by 295
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
Weng, L.-C. C., Preis, S. R., Hulme, O. L., Larson, M. G., Choi, S. H., Wang, B., Trinquart, L., McManus, D. D., Stærk, L., Lin, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031431 · Cited by 276
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes
Westerman, S. B., & WENGER, N. K. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x15666181205110624 · Cited by 287
Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., & Guo, J. (2024) · EP Europace · doi:10.1093/europace/euae195 · Cited by 285
Chung, M. K., Refaat, M. M., Shen, W.-K., Kutyifa, V., Cha, Y., Biase, L. D., Baranchuk, A. M., Lampert, R., Natale, A., Fisher, J. D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.025 · Cited by 261
Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status
Mou, L., Norby, F. L., Chen, L. Y., O’Neal, W. T., Lewis, T. T., Loehr, L. R., Soliman, E. Z., & Alonso, Á. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006350 · Cited by 248
Aune, D., Feng, T., Schlesinger, S., Janszky, I., Norat, T., & Ríboli, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.02.004 · Cited by 251
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.07.003 · Cited by 241
Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation
Wong, C. X. J., Sun, M. T., Odutayo, A., Emdin, C. A., Mahajan, R., Lau, D. H., Pathak, R. K., Wong, D. T. L., Selvanayagam, J. B., Sanders, P., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004378 · Cited by 231
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258
Animal models of arrhythmia: classic electrophysiology to genetically modified large animals
Clauß, S., Bleyer, C., Schüttler, D., Tomsits, P., Renner, S., Klymiuk, N., Wakili, R., Maßberg, S., Wolf, E., & Kääb, S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0179-0 · Cited by 233
Comorbidity of atrial fibrillation and heart failure
Ling, L., Kistler, P. M., Kalman, J. M., SCHILLING, R. J., & Hunter, R. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.191 · Cited by 217
Revised Framingham Stroke Risk Profile to Reflect Temporal Trends
Dufouil, C., Beiser, A., McClure, L. A., Wolf, P. A., Tzourio, C., Howard, V. J., Westwood, A. J., Himali, J. J., SULLIVAN, L. M., Aparicio, H. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.115.021275 · Cited by 217
Ko, D., Chung, M. K., Evans, P. T., Benjamin, E. J., & Helm, R. H. (2024) · JAMA · doi:10.1001/jama.2024.22451 · Cited by 232
Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects
Jamaly, S., Carlsson, L. M. S., Peltonen, M., Jacobson, P., Sjöström, L., & Karason, K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.940 · Cited by 205
Role of inflammatory signaling in atrial fibrillation
Scott, L., Li, N., & Dobrev, D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.020 · Cited by 196
Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy
Nwabuo, C. C., & Vasan, R. S. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1017-9 · Cited by 208
The future of atrial fibrillation management: integrated care and stratified therapy
Kirchhof, P. F. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31072-3 · Cited by 182
Gopinathannair, R., Chen, L. Y., Chung, M. K., Cornwell, W. K., Furie, K. L., Lakkireddy, D. R., Marrouche, N. F., Natale, A., Olshansky, B., & Joglar, J. A. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/hae.0000000000000078 · Cited by 187
Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)
Bizhanov, K. A., Аbzaliyev, K., Baimbetov, A. K., Sarsenbayeva, A., & Lyan, E. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15759 · Cited by 182
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Lip, G. Y. H., Proietti, M., Potpara, T., MANSOUR, M. C., Savelieva, I., Tse, H., Goette, A., Camm, A. J., Blomström‐Lundqvist, C., Gupta, D., et al. (2023) · EP Europace · doi:10.1093/europace/euad226 · Cited by 176
Lee, S., Choi, E., Han, K., Cha, M., & Oh, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.039 · Cited by 165
Wiczer, T. E., Levine, L. B., Brumbaugh, J., Coggins, J., Zhao, Q., Ruppert, A. S., Rogers, K. A., McCoy, A., Mousa, L., Guha, A., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009720 · Cited by 164
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.04.017 · Cited by 160
Caldeira, D., Alves, D., Costa, J. N., Ferreira, J. J., & Pinto, F. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211228 · Cited by 158
Coronary heart disease and atrial fibrillation: a vicious cycle
Liang, F., & Wang, Y. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00702.2020 · Cited by 157
Risk Factor Management in Atrial Fibrillation
Brandes, A., Smit, M. D., Nguyen, B. O., Rienstra, M., & Gelder, I. C. V. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.18.2 · Cited by 163
Ideal Blood Pressure in Patients With Atrial Fibrillation
Kim, D., Yang, P., Kim, T., Jang, E., Shin, H. J., Kim, H. Y., Yu, H. T., Uhm, J., Kim, J., Pak, H., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.076 · Cited by 155
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Becher, N., Metzner, A., Toennis, T., Kirchhof, P. F., & Schnabel, R. B. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae373 · Cited by 169
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157
Risk of Atrial Fibrillation According to Cancer Type
Yun, J. P., Choi, E., Han, K., Park, S. H., Jung, J., Park, S. H., Ahn, H., Lim, J., Lee, S., & Oh, S. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.03.006 · Cited by 153
The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
Bohne, L. J., Johnson, D., Rose, R. A., Wilton, S. B., & Gillis, A. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00135 · Cited by 153
Mezzatesta, S., Torino, C., Meo, P. D., Fiumara, G., & Vilasi, A. D. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.05.005 · Cited by 151
Computational Diagnostic Techniques for Electrocardiogram Signal Analysis
Xie, L., Li, Z., Zhou, Y., He, Y., & Zhu, J. (2020) · Sensors · doi:10.3390/s20216318 · Cited by 166
Epidemiology of Atrial Fibrillation
Zhang, J., Johnsen, S. P., Guo, Y., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.10.010 · Cited by 150
Fabritz, L., Guasch, E., Antoniades, C. A., Bardinet, I., Benninger, G., Betts, T. R., Brand, E., BREITHARDT, G. E., Suchánková, G., Camm, A. J., et al. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.194 · Cited by 144
Cowan, J. C., Wu, J., Hall, M., Orlowski, A., West, R. M., & Gale, C. P. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy411 · Cited by 142
Chua, W., Purmah, Y., Cardoso, V. R., Gkoutos, G. V., Tull, S. P., Neculau, G., Thomas, M. R., Kotecha, D., Lip, G. Y. H., Kirchhof, P. F., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy815 · Cited by 140
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
Welton, N. J., McAleenan, A., Thom, H. H. Z., Davies, P. A., Hollingworth, W., Higgins, J. P. T., Okoli, G. N., Sterne, J. A. C., Feder, G. S., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21290 · Cited by 142
Odening, K. E., Deiß, S., Dilling-Boer, D. M., Didenko, M., Eriksson, U., Nedios, S., Ng, F. S., Roca‐Luque, I., Borque, P. S., Vernooy, K., et al. (2018) · EP Europace · doi:10.1093/europace/euy215 · Cited by 138
Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective
Simons, S. O., Elliott, A. D., Sastry, M., Hendriks, J., Arzt, M. E., Rienstra, M., Kalman, J. M., Heidbüchel, H., Nattel, S., Wesseling, G., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa822 · Cited by 138
Genetic Obesity and the Risk of Atrial Fibrillation
Chatterjee, N. A., Giulianini, F., Geelhoed, B., Lunetta, K. L., Misialek, J. R., Niemeijer, M. N., Rienstra, M., Rose, L. M., Smith, A. V., Arking, D. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024921 · Cited by 136
Atrial Fibrillation and Ventricular Arrhythmias
Gillis, A. M. (2017) · Circulation · doi:10.1161/circulationaha.116.025312 · Cited by 135
The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey
Wang, Z., Chen, Z., Wang, X., Zhang, L., Li, S., Tian, Y., Shao, L., Hu, H., & Gao, R. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.05.015 · Cited by 130
Guan, C., Gong, A., Zhao, Y., Yin, C., Geng, L., Liu, L., Yang, X., Lu, J., & Xiao, B. (2024) · Critical Care · doi:10.1186/s13054-024-05138-0 · Cited by 133
Defining Dysbiosis in Patients with Urolithiasis
Zampini, A. M., Nguyen, A. H., Rose, E., Monga, M., & Miller, A. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-41977-6 · Cited by 131
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 134
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 130
Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation
Christopoulos, G., Graff‐Radford, J., Lopez, C., Yao, X., Attia, Z. I., Rabinstein, A. A., Petersen, R. C., Knopman, D. S., Mielke, M. M., Kremers, W. K., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009355 · Cited by 134
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 136
Jakobsen, C., Lamberts, M., Carlson, N., Lock‐Hansen, M., Torp-Pedersen, C. T., Gislason, G., & Schou, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-6314-9 · Cited by 123
Chamberlain, A. M., Alonso, Á., Gersh, B. J., Manemann, S. M., Killian, J. M., Weston, S. A., Byrne, M., & Roger, V. L. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.11.008 · Cited by 125
Vinter, N., Cordsen, P., Johnsen, S. P., Stærk, L., Benjamin, E. J., Frost, L., & Trinquart, L. (2024) · BMJ · doi:10.1136/bmj-2023-077209 · Cited by 121
Jani, B., Nicholl, B. I., McQueenie, R., Connelly, D. T., Hanlon, P., Gallacher, K., Lee, D., & Mair, F. S. (2017) · EP Europace · doi:10.1093/europace/eux322 · Cited by 118
Xiong, Z., Liu, T., Tse, G., Gong, M., Gladding, P. A., Smaill, B. H., Stiles, M. K., Gillis, A. M., & Zhao, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00835 · Cited by 118
Kotecha, D., BREITHARDT, G. E., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., Arnar, D. O., Atar, D., Auricchio, A., Bax, J. J., et al. (2018) · EP Europace · doi:10.1093/europace/eux318 · Cited by 117
Atrial Fibrillation and Ischemic Stroke: A Clinical Review
Migdady, I., Russman, A., & Buletko, A. B. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726332 · Cited by 130
Is Atrial Fibrillation a Preventable Disease?
Du, X., Dong, J., & Ma, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.020 · Cited by 117
Wong, G. R., Nalliah, C. J., Lee, G., Voskoboinik, A., Chieng, D., Prabhu, S., Parameswaran, R., Sugumar, H., Al-Kaisey, A., McLellan, A., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.009925 · Cited by 117
Edoxaban in Asian Patients With Atrial Fibrillation
Lee, S., Choi, E., Han, K., Jung, J., Oh, S., & Lip, G. Y. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.066 · Cited by 112
Emerging Technologies for Pulmonary Vein Isolation
Ramirez, F. D., Reddy, V. Y., Viswanathan, R., Hocini, M., & Jaı̈s, P. (2020) · Circulation Research · doi:10.1161/circresaha.120.316402 · Cited by 113
Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation
Deshmukh, A. J., Iglesias, M., Khanna, R., & Beaulieu, T. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.07.010 · Cited by 109
Metadata
- Authors
- Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., Seshadri, S., Wolf, P. A., Vasan, R. S., Benjamin, E. J., & Levy, D.
- Affiliations
- Framingham Heart Study (US)
- Boston University (US)
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Schnabel, Renate B
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 386
- Issue
- 9989
- Pages
- 154-162
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4553037
- OpenAlex
- W1924098982
- Cited by
- 1,746
- References
- 32
- Citations by year
- 2026: 126 · 2025: 209 · 2024: 253 · 2023: 192 · 2022: 198 · 2021: 155 · 2020: 145 · 2019: 141 · 2018: 120 · 2017: 110 · 2016: 76 · 2015: 20
- FWCI
- 79.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- NIH/NHLBI (contract N01-HC-25195, grant 1K23HL114724)
- NIH (grants 1RC1HL101056, HL102214, and AG028321, grant 2R01HL092577, grants 1U01HL105268-01 and KL2RR031981)
- Fondation Leducq (14CVD01) and NIH grants (1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780)
- American Heart Association Established Investigator Award (13EIA14220013)
- Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program (SCHN 1149/3-2)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- atrial fibrillation, prevalence trends, incidence trends, sex differences, risk factors, stroke, mortality, Framingham Heart Study, electrocardiogram screening, atrial fibrillation screening, atrial fibrillation prevention, cardiovascular disease prevention, long-term cohort follow-up
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Mortality, Risk Factors, United States, Cohort Studies, Incidence, Prevalence, Age Distribution, Sex Distribution, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
